Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.
Breast cancer survivor
Chronic postsurgical pain
Fear of recurrence
Quality of life
Journal
Breast cancer (Tokyo, Japan)
ISSN: 1880-4233
Titre abrégé: Breast Cancer
Pays: Japan
ID NLM: 100888201
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
07
03
2021
accepted:
11
07
2021
pubmed:
23
7
2021
medline:
27
1
2022
entrez:
22
7
2021
Statut:
ppublish
Résumé
Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors. We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP. In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP. This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors.
METHODS
METHODS
We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP.
RESULTS
RESULTS
In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP.
CONCLUSIONS
CONCLUSIONS
This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
Identifiants
pubmed: 34292500
doi: 10.1007/s12282-021-01275-4
pii: 10.1007/s12282-021-01275-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1346-1357Informations de copyright
© 2021. The Japanese Breast Cancer Society.
Références
Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26:428–45.
doi: 10.1007/s12282-018-00941-4
Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the Nation on the Status of Cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Instit. 2015;107:djv048.
doi: 10.1093/jnci/djv048
de Gelder R, Heijnsdijk EAM, Fracheboud J, Draisma G, de Koning HJ. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy. Int J Cancer. 2015;137:165–72.
doi: 10.1002/ijc.29364
Mehdi S, Abbas H, Al A, Hosein M, Khadije R, Keikhaie R. Health-related quality of life of breast cancer patients in the Eastern Mediterranean region: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;174:585–96. https://doi.org/10.1007/s10549-019-05131-0 .
doi: 10.1007/s10549-019-05131-0
Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156:2413–22.
doi: 10.1097/j.pain.0000000000000298
Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M, Yamaguchi Y, et al. Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study. J Pain Res. 2018;11:2197–206.
doi: 10.2147/JPR.S171680
Wang L, Cohen JC, Devasenapathy N, Hong BY, Kheyson S, Lu D, et al. Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies. Br J Anaesth. 2020;125:346–57. https://doi.org/10.1016/j.bja.2020.04.088 .
doi: 10.1016/j.bja.2020.04.088
pubmed: 32611524
Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ. 2013;346:f1865.
doi: 10.1136/bmj.f1865
Burckhardt CS, Jones KD. Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. Health Qual Life Outcome. 2005;3:30.
doi: 10.1186/1477-7525-3-30
Marschner N, Trarbach T, Rauh J, Meyer D, Müller S, Johanna H, et al. Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project. Breast Cancer Res Treat. 2019;175:701–12. https://doi.org/10.1007/s10549-019-05197-w .
doi: 10.1007/s10549-019-05197-w
pubmed: 30868393
pmcid: 6534521
Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life. Breast Cancer Res Treat. 2018;167:157–69.
doi: 10.1007/s10549-017-4485-0
Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, et al. Patient’s perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology. 2011;20:497–505.
doi: 10.1002/pon.1757
van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology. 2008;17:1137–45.
doi: 10.1002/pon.1340
Mishel MH, Germino BB, Gil KM, Belyea M, Laney IC, Stewart J, et al. Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho Oncology. 2005;14:962–78.
doi: 10.1002/pon.909
Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25:16–24.
doi: 10.1207/S15324796ABM2501_03
Akechi T, Momino K, Yamashita T, Fujita T, Hayashi H, Tsunoda N, et al. Contribution of problem-solving skills to fear of recurrence in breast cancer survivors. Breast Cancer Res Treat. 2014;145:205–10.
doi: 10.1007/s10549-014-2929-3
Momino K, Akechi T, Yamashita T, Fujita T, Hayahi H, Tsunoda N, et al. Psychometric properties of the Japanese version of the concerns about recurrence scale (CARS-J). Jpn J Clin Oncol. 2014;44:456–62.
doi: 10.1093/jjco/hyu032
Akechi T, Momino K, Iwata H. Brief screening of patients with distressing fear of recurrence in breast cancer survivors. Breast Cancer Res Treat. 2015;153:475–6.
doi: 10.1007/s10549-015-3537-6
Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, et al. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004;109:103–9.
doi: 10.1016/j.pain.2004.01.015
Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–6.
doi: 10.1056/NEJM199403033300902
Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996;67:267–73.
doi: 10.1016/0304-3959(96)03131-4
Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23:129–38.
Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014;155:232–43.
doi: 10.1016/j.pain.2013.09.028
van Helmond N, Timmerman H, van Dasselaar NT, van de Pol CC, Olesen SS, Drewes AM, et al. High body mass index is a potential risk factor for persistent postoperative pain after breast cancer treatment. Pain Physician. 2017;20:E661–71.
pubmed: 28727711
Manfuku M, Nishigami T, Mibu A, Tanaka K, Kitagaki K, Sumiyoshi K. Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls. Breast Cancer. 2019;26:758–65. https://doi.org/10.1007/s12282-019-00979-y .
doi: 10.1007/s12282-019-00979-y
pubmed: 31127501
Roth RS, Qi J, Hamill JB, Kim HM, Ballard TNS, Pusic AL, et al. Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction. Breast. 2018;37:119–25.
doi: 10.1016/j.breast.2017.11.001
Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66:195–205.
doi: 10.1016/0304-3959(96)03064-3
Tait RC, Zoberi K, Ferguson M, Levenhagen K, Luebbert RA, Rowland K, et al. Persistent post-mastectomy pain: risk factors and current approaches to treatment. J Pain. 2018;19:1367–83.
doi: 10.1016/j.jpain.2018.06.002
Reyad RM, Omran AF, Abbas DN, Kamel MA, Shaker EH, Tharwat J, et al. The possible preventive role of pregabalin in postmastectomy pain syndrome: a double-blinded randomized controlled trial. J Pain Symptom Manage. 2019;57:1–9. https://doi.org/10.1016/j.jpainsymman.2018.10.496 .
doi: 10.1016/j.jpainsymman.2018.10.496
pubmed: 30359684
Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. JCO. 2019;37:2899–915.
doi: 10.1200/JCO.19.00572